Lawmakers Take Aim at Compounding, Push for More FDA Authority

U.S. lawmakers want the FDA to explain who regulates the 28,000 compounding pharmacies operating in the country and how the agency can better control them. The Congressional activity is in response to a national health scare that involves the New England Compounding Center (NECC) in Framingham, Mass. Twelve deaths have been reported and more than 100 patients affected following injections of steroids produced by the compounder.
Drug Industry Daily